World Asset Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$219K Sell
1,055
-113
-10% -$24.9K 0.02% 771
2021
Q2
$248K Buy
1,168
+115
+11% +$21.1K 0.02% 763
2021
Q1
$249K Buy
+1,053
New +$210K 0.02% 769
2018
Q1
Sell
-539
Closed -$13K 1413
2017
Q4
$13K Buy
539
+18
+3% +$439 ﹤0.01% 1496
2017
Q3
$12K Buy
+521
New +$11.7K ﹤0.01% 1529
2016
Q4
Sell
-530
Closed -$22K 1393
2016
Q3
$22K Buy
+530
New +$68.4K ﹤0.01% 1379
2014
Q4
Sell
-530
Closed -$44K 1444
2014
Q3
$44K Sell
530
-10
-2% -$904 ﹤0.01% 1462
2014
Q2
$50K Buy
+540
New +$47.5K ﹤0.01% 1509
2013
Q4
Sell
-631
Closed -$40K 1622
2013
Q3
$40K Hold
631
﹤0.01% 1692
2013
Q2
$26K Buy
+631
New +$27.3K ﹤0.01% 1773

Other funds holding NVAX

World Asset Management's NVAX Position: Q3 2021 in Review

World Asset Management reduced its Novavax (NVAX) stake by 9.7% in Q3 2021, selling an estimated $24.9K and leaving 1,055 shares worth $219K. The position accounts for 0.02% of the portfolio, ranked #771.

World Asset Management first reported a position in NVAX in Q2 2013 and has held it in 10 quarters since. The position peaked at $249K in Q1 2021. 442 funds tracked by Wall St. Rank hold NVAX as of Q3 2021.

  • World Asset Management held 1,055 shares of Novavax worth $219K as of Q3 2021.
  • World Asset Management sold 113 Novavax shares in Q3 2021, an estimated $24.9K.
  • Novavax made up 0.02% of World Asset Management's portfolio in Q3 2021, its #771 holding.
  • World Asset Management first reported a position in Novavax in Q2 2013 and has held it in 10 quarters since.
  • World Asset Management's Novavax position peaked at $249K in Q1 2021.
  • 442 funds tracked by Wall St. Rank held Novavax as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.